anecortave acetate has been researched along with prednisolone in 3 studies
*Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. [MeSH]
*Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. [MeSH]
| Studies (anecortave acetate) | Trials (anecortave acetate) | Recent Studies (post-2010) (anecortave acetate) | Studies (prednisolone) | Trials (prednisolone) | Recent Studies (post-2010) (prednisolone) |
|---|---|---|---|---|---|
| 68 | 9 | 6 | 34,414 | 3,302 | 7,141 |
| Protein | Taxonomy | anecortave acetate (IC50) | prednisolone (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Homo sapiens (human) | 0.0278 | |
| Progesterone receptor | Homo sapiens (human) | 2.08 | |
| Glucocorticoid receptor | Rattus norvegicus (Norway rat) | 0.0565 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.016 | |
| Mineralocorticoid receptor | Homo sapiens (human) | 0.0322 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.016 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.016 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.016 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Damsker, JM; Hoffman, EP; McCall, JM; Nagaraju, K; Reeves, EKM | 1 |
| Candia, OA; Gerometta, R; Millar, JC; Podos, SM | 1 |
| Kaufman, PL | 1 |
3 other study(ies) available for anecortave acetate and prednisolone
| Article | Year |
|---|---|
VBP15: preclinical characterization of a novel anti-inflammatory delta 9,11 steroid.
Topics: Animals; Anti-Inflammatory Agents; Cell Nucleus; Cell Survival; Dogs; Drug Evaluation, Preclinical; Glucocorticoids; Haplorhini; Humans; Male; Mice; NF-kappa B; Pregnadienediols; Rats | 2013 |
Suppression of corticosteroid-induced ocular hypertension in sheep by anecortave.
Topics: Administration, Topical; Angiogenesis Inhibitors; Animals; Aqueous Humor; Disease Models, Animal; Female; Glucocorticoids; Injections; Intraocular Pressure; Ocular Hypertension; Prednisolone; Pregnadienediols; Sheep; Tonometry, Ocular | 2010 |
Suppression and reduction of corticosteroid-induced ocular hypertension by anecortave in sheep.
Topics: Angiogenesis Inhibitors; Animals; Disease Models, Animal; Glucocorticoids; Intraocular Pressure; Ocular Hypertension; Prednisolone; Pregnadienediols; Sheep; Tonometry, Ocular | 2010 |